Nachrichten zur Pfizer Aktie

Valneva outlines $145M-$160M 2026 revenue guidance while Pfizer targets Lyme decisions within 12 months

…

PLX: Elfabrio Estimates Up

By John Vandermosten, CFANYSE: PLXREAD THE FULL PLX RESEARCH REPORTSecond Quarter 2026 Financial and Operational ReviewProtalix BioTherapeutics, Inc. (NYSE: PLX)…

Will Pfizers Non-COVID Portfolio Drive Its Next Phase of Growth?

PFEs non-COVID products are gaining momentum, with launches, acquisitions and a pipeline aimed at driving growth from 2029 onward.…

Valneva Aktie: Borreliose-Impfstoff als großer Wachstumstreiber - Kursziel 12 Dollar

New York (www.aktiencheck.de) - Valneva-Aktienanalyse von TD Cowen:Die Analysten von TD Cowen nehmen die Coverage für die Aktie von Valneva…

Pfizer Just Raised Its 2026 Guidance -- but the Boost Leans Heavily on a Drug Running Out the Patent Clock

This problem has a solution, and Pfizer is implementing it.…

Pfizers Earnings Have Declined 58% This Year. Is a Dividend Cut Around the Corner?

The stocks 6.4% yield is attractive, but it comes with risk.…

Pfizer Aktie: Milliarden-Abschreibungen und verschärftes Sparprogramm

Frankfurt (www.aktiencheck.de) - Pfizer-Aktienanalyse von XTB:Der US-Pharmagigant Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE, NYSE-Symbol: PFE) hat mit seinen…

Berenberg belässt Pfizer auf Hold - Ziel 25 Dollar

HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Pfizer nach Quartalszahlen auf "Hold" mit einem Kursziel von…

ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 28 Dollar

NEW YORK (dpa-AFX) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach Zahlen zum…

US-Pharmakonzern Pfizer wächst unerwartet stark - Umsatzziel angehoben

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer blickt nach einem unerwartet starken Wachstum im zweiten…

Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs

Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion…

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Pfizer beat Wall Street estimates for ?second-quarter profit on Tuesday, driven by strong demand for ?its blood thinner, Eliquis.…

Pfizer raises revenue outlook after quarterly earnings top estimates

Pfizer Inc (NYSE:PFE, XETRA:PFE) beat Wall Street expectations for its second-quarter 2026 results and raised the midpoint of its full-year…

Pfizers Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buying for Its 6.9% Yield?

The stocks yield is more than six times the S&P 500 average.…

Are These 5 Pharma Stocks Set to Surpass Q2 Earnings Forecasts?

Amgen, Pfizer, Eli Lilly, Merck and Novo Nordisk are set to report Q2 results this week after a strong start…

Pfizer Yields 6.8%, Trades at 8.5X Earnings, and Has a Promising Late-Stage Weight Loss Drug. Why Are So Many Investors Still Ignoring the Stock?

There is more to this stock than meets the eye.…

Pfizers Bear Case Is Breaking

…

Pfizer Stock Ahead of Q2 Earnings: To Buy or Not to Buy?

Pfizer heads into Q2 earnings with expectations for growth in key products, COVID headwinds, and guidance updates that could shape…

Schutz vor dem KI-Rücksetzer: Jefferies rät zu Dividenden-Schwergewichten - diese Aktien stechen heraus

Jefferies rät zu Aktien mit niedriger Volatilität und hoher DividendeProcter & Gamble, Pfizer, KeyCorp und Simon Property Group stehen im…

Pfizer (PFE) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

Pfizer: Calling The Bottom - The Patent Cliff Is Real, But The Valuation Has Fallen Too Far

…

Pfizers Dividend Yield Looks Almost Too Good. Heres Why Management Isnt Worried.

Pfizer has a 6.8% yield at a time when the markets yield is roughly 1%: Is there something wrong?…

Is Pfizers 7% Dividend Yield Too Good to Be True? Heres the Straight Answer

Income seekers shouldnt give up on the stock yet.…

Pfizer (PFE) Falls More Steeply Than Broader Market: What Investors Need to Know

In the latest trading session, Pfizer (PFE) closed at $24.75, marking a -1.2% move from the previous day.…

Looking for Cheap Income Stocks? Why Pfizer Belongs on Your Shortlist Right Now

Pfizer is a highly respected drug company facing normal industry headwinds.…

Heres How Pfizers Oncology Growth Story Looks Ahead of Q2 Results

PFEs oncology business is in focus ahead of Q2 results as growth from key cancer drugs, biosimilars and pipeline updates…

Pfizer Has the Highest-Yielding Dividend in the S&P 500. Should Investors Be Worried?

The pharma giants yield of around 7.1% is more than six times the S&P 500 average.…

CEO Chat with Dr. Kelvin Cooper, CEO of Lakewood-Amedex Biotherapeutics

NASDAQ: LABTDavid Bautz, PhD: Welcome to our next episode in our CEO Chat series. My name is David Bautz. Im…

Pfizer Aktie: Droht jetzt neuer Gegenwind?

Charlotte (www.aktiencheck.de) - Pfizer-Aktienanalyse der Bank of America (BofA):BofA habe das Kursziel für die Aktie von Pfizer Inc. (ISIN: US7170811035,…

FDA Expands MRK & PFEs Keytruda-Padcev Combo Use in Bladder Cancer

Mercks Keytruda in combination with Pfizers Padcev wins FDA nod for expanded use in muscle-invasive bladder cancer, regardless of cisplatin…

Pfizer: The AI Hedge That Pays You To Stay Defensive

Pfizer remains an undervalued diversification play, underperforming the benchmark but increasing 2% since prior coverage. Learn why PFE stock is…

Is Pfizer on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market?

So far, Pfizer has been an also-ran in the GLP-1 race, but that could change if its long-acting weight-loss medication…

Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?

Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Pfizer Sector Perform

NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Pfizer mit einem Kursziel von 25 US-Dollar…

JPMorgan resets LLY stock target on drug demand

Eli Lilly (LLY) keeps setting records, and Wall Street’s rating of its stock keeps increasing as well.  On Tuesday, one…

Opinion: Pfizers Dividend Is Riskier Than You Might Think

A 7% dividend yield will grab your attention, but be sure to read the fine print.…

Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?

AZN targets continued 2026 growth with expanding blockbuster medicines, a strong pipeline and 2030 revenue goals as it outpaces Pfizer…

Pfizer (PFE) Stock Sinks As Market Gains: Heres Why

Pfizer (PFE) concluded the recent trading session at $23.72, signifying a -2.47% move from its prior days close.…

Jefferies belässt Pfizer auf Buy - Ziel 34 Dollar

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Pfizer mit einem Kursziel von 34 US-Dollar auf "Buy" belassen. Mit…

House committee investigates Merck, AbbVie over China trials

Five of the biggest names in American pharma just got a deadline from Washington. The House Select Committee on China…

Pfizer vs Verizon Communications: Which High-Yielding Dividend Stock Is the Better Buy?

These stocks offer high yields, are big names in their respective sectors, and have strong fundamentals.…

Why Pfizer Could Prove to Be an Underrated GLP-1 Stock

It could prove to be a case of better later than never for the healthcare giant.…

Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now

Pfizer is deeply out of favor on Wall Street, which could be a huge opportunity for long-term dividend investors.…

Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now

Pfizer is deeply out of favor on Wall Street, which could be a huge opportunity for long-term dividend investors.…

2026 Mid-Year Outlook: Big Market Risks, AI And Memory Mania Concerns, And My Top Bargain Stock Picks

Broad market bearishness prompts defensive buys in oversold defense stocks, high-yield Pfizer, and cash reserves. Read more here.…

AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?

AbbVie and Pfizer are taking divergent paths to navigate patent expirations and competition. Dig into their financials, risk profiles, and…

Nike names former Pfizer CFO David Denton as finance chief

Nike Inc (NYSE:NKE, XETRA:NKE) has announced that David Denton will join the company as executive vice president and chief financial…

Pfizer Aktie: Pipelineerfolge dringend notwendig

Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt in einer…

LLY or PFE: Which Drugmaker Offers the Stronger Growth Story?

Lillys GLP-1 leadership, expanding pipeline and strong earnings growth outlook make it a standout pick over Pfizer despite its premium…

BMO reiterates Pfizer stock Outperform on pipeline strength

BMO reiterates Pfizer stock Outperform on pipeline strength…